Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy.
about
Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.Ionizing radiation induces tumor cell lysyl oxidase secretion.Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumorsAugmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors.Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxiaRole of EGFR as prognostic factor in head and neck cancer patients treated with surgery and postoperative radiotherapy: proposal of a new approach behind the EGFR overexpression.Cytokine and growth factor responses after radiotherapy for localized ependymoma.Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer models.Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.PET-CT for radiotherapy treatment planning and response monitoring in solid tumors.Knockdown of PKM2 Enhances Radiosensitivity of Non-small cell Lung Cancer.EBUS and EUS guided fine needle aspirations for molecular diagnostic analysis in lung cancer.Multikinase inhibitors sorafenib and sunitinib as radiosensitizers in head and neck cancer cell lines.Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model.
P2860
Q30438929-52F5931F-8476-4A3D-A5EA-C0DC1C3E4E4FQ33591405-B8D6B9C7-E75D-4044-931D-B8A4F0D68BB2Q34469812-780B1935-8283-4996-9C78-F6A91327C6ADQ35103263-1A216F1D-242A-48F8-801D-703750BE3B09Q35550182-F1B50C4B-F259-4BBC-BBC3-8CF82A9AC8ABQ36100135-D7137971-DB68-47D1-B8AE-02DEC46B9A76Q36357543-6D81515C-6166-44D2-A64D-C418E7D04CEFQ36525734-4FECE2F2-BC84-4796-939A-5DE9452EA193Q36770297-FF75EB4F-FB8B-421E-976C-B7F2A58EA49CQ37709253-19BFB266-09DC-4805-8926-1F7C9C4EC424Q37832131-AA343157-5E0C-4D5E-8B3C-F6A4B2C0686BQ38913227-0747A3A2-C82A-4B0C-99B5-ED944E4F450BQ47896289-6BA6BA9D-85C7-48B6-835F-0A2F91178D00Q51129504-C67A6165-0449-4B07-8A04-0EAEA3D91064Q53265601-AF9F19FE-0017-4FFE-86CB-6D64C51C51FB
P2860
Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Microenvironmental transformat ...... esponsiveness to radiotherapy.
@ast
Microenvironmental transformat ...... esponsiveness to radiotherapy.
@en
type
label
Microenvironmental transformat ...... esponsiveness to radiotherapy.
@ast
Microenvironmental transformat ...... esponsiveness to radiotherapy.
@en
prefLabel
Microenvironmental transformat ...... esponsiveness to radiotherapy.
@ast
Microenvironmental transformat ...... esponsiveness to radiotherapy.
@en
P1476
Microenvironmental transformat ...... esponsiveness to radiotherapy.
@en
P2093
Albert J van der Kogel
Johannes H A M Kaanders
P356
10.1016/J.RADONC.2006.10.022
P577
2006-12-04T00:00:00Z